Search Results for: International Stem Cell Corporation Completes
Articles
March 16, 2018
International Stem Cell Corporation Completes Dosing of Second Cohort in Parkinson's Disease Trial March 16, 2018
International Stem Cell Corporation recently announced the eighth participant, which completes the dosing of the second cohort of the clinical...
March 13, 2018
International Stem Cell Corporation Completes Dosing of Second Cohort in Parkinson's Disease Trial March 13, 2018
International Stem Cell Corporation recently announced the eighth participant, which completes the dosing of the second cohort of the clinical...
May 2, 2019
International Stem Cell Completes Enrollment & Dosing in its Parkinson's Disease Clinical Trial May 2, 2019
International Stem Cell Corporation recently announced the completion of subject enrollment in its Phase 1 clinical trial of ISC-hpNSC for...
December 18, 2014
FUJIFILM Completes Acquisition of Biotherapeutics Company December 18, 2014
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, recently announced the completion of its acquisition of Kalon Biotherapeutics LLC,...
October 6, 2015
ADVANCED DELIVERY DEVICES - Implantable Drug-Eluting Devices: A Novel Approach to Patient Care October 6, 2015
Samuel D. Trohman, MBA, Joey L. Glassco, Elena Draganoiu, PhD, and Carey Boyum present developmental and commercial examples of non-biodegradable drug-eluting devices, along with the versatile properties of thermoplastic polyurethanes for the development of effective drug delivery systems.
December 11, 2011
12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...
August 11, 2011
8/16/2011 August 11, 2011
Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing...
March 13, 2011
3/15/2011 March 13, 2011
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development...
